New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects. Naveen Pemmaraju, MD, with The University of Texas MD Anderson Cancer Center in Houston, and colleagues reviewed the records of 64 male patients with breast can...